Stevanato Group (NYSE:STVN) Trading Down 2.1% – Time to Sell?

Shares of Stevanato Group S.p.A. (NYSE:STVNGet Free Report) were down 2.1% during trading on Monday . The stock traded as low as €19.56 ($20.59) and last traded at €19.61 ($20.64). Approximately 78,887 shares changed hands during trading, a decline of 84% from the average daily volume of 506,669 shares. The stock had previously closed at €20.03 ($21.08).

Analysts Set New Price Targets

Several analysts have recently commented on STVN shares. Citigroup decreased their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley reaffirmed an “equal weight” rating and set a $23.00 target price (down from $24.00) on shares of Stevanato Group in a research note on Tuesday.

Check Out Our Latest Report on STVN

Stevanato Group Price Performance

The business’s 50 day simple moving average is €19.50 and its 200 day simple moving average is €19.59. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVNGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. During the same period in the prior year, the firm posted $0.16 earnings per share. Stevanato Group’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

Several large investors have recently modified their holdings of STVN. Conestoga Capital Advisors LLC raised its stake in shares of Stevanato Group by 5.5% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock worth $153,518,000 after acquiring an additional 400,087 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock worth $55,698,000 after acquiring an additional 1,123,104 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Stevanato Group by 4.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after acquiring an additional 115,050 shares in the last quarter. Bamco Inc. NY raised its stake in shares of Stevanato Group by 1.3% during the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after acquiring an additional 21,469 shares in the last quarter. Finally, Fred Alger Management LLC raised its stake in shares of Stevanato Group by 24.2% during the 3rd quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock worth $21,411,000 after acquiring an additional 208,830 shares in the last quarter.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.